T1	Participants 49 92	patients assessed via immersion calorimetry
T2	Participants 316 416	resting metabolic rate is enhanced to evaluate the effects of sibutramine treatment on thermogenesis
T3	Participants 418 462	Sixty obese women were included in the study
T4	Participants 473 550	were divided into 2 equal groups-the placebo and sibutramine treatment groups
T5	Participants 556 607	sibutramine group was given sibutramine 10 mg daily
T6	Participants 677 756	thermogenic measurements were taken with the use of water immersion calorimetry
